Learn about COPD-associated eosinophilic inflammation and how it may influence treatment.
How real is ACOS as a diagnosis?
Review key results and reanalyses from clinical trials investigating combination therapy in COPD.
Learn about the components of eCigarettes and their potential dangers.
This module covers the latest news from the ATS 2016 on COPD pathogenesis and lung cell structure.
Build your knowledge on the potential and potential pitfalls of eCigarettes with this Hot Topic from the ATS 2016.
Stay up-to-date on new insights into the pathophysiology of COPD with this Hot Topic from the ATS 2016.
Learn more about eosinophils and COPD in this Hot Topic from the ATS 2016.
Get more details on the new data presented at the ATS 2016 on combination therapy in this Hot Topic.
Using this link will let you leave a website of Boehringer Ingelheim International GmbH (“BI”) or to a different domain under the control of BI. In the event that the linked site is not under the control of BI but under the control of a third party or an affiliate in the Boehringer Ingelheim group of companies, BI shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites. This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by BI of the site.